I don't think we should be leveling blame at anyone as we don't really know the inner workings of the company and the whole business model, as well as the obstacles to get sales. Sure, having Sozo recommended in the NCCN guidelines for lymphedema helps but to actually see sales increase could take some time under any management.
I don't think we should be leveling blame at anyone as we don't...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.5¢ |
Change
-0.001(1.16%) |
Mkt cap ! $171.9M | |||
| Open | High | Low | Value | Volume |
| 8.6¢ | 8.7¢ | 8.3¢ | $82.45K | 971.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 156801 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 171549 | 2 |
View Market Depth
| Last trade - 12.44pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.4¢ |
Change
-0.001 ( 3.23 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.7¢ | 8.3¢ | 455088 | ||
| Last updated 13.16pm 29/04/2024 ? | |||||
| IPD (ASX) Chart |